1-12 of 12
Petra Blahovcová
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intensified Immunochemotherapy with Autologous Stem Cell Transplantation for Mantle Cell Lymphoma - Could It Still be Considered the Standard of Care?

Liliana Tuskova, Diana Maláriková, Katerina Benesova, Eva Konirova, Kamila Polgarova, Petra Blahovcova, Jana Salkova, Marek Trněný, Pavel Klener
Journal: Blood
Blood (2024) 144 (Supplement 1): 3012.
https://doi.org/10.1182/blood-2024-198865
Published: 2024
Journal Articles

The Survival Improvement of Transplant-Eligible Primary CNS Lymphoma Patients within Last 15 Years

Prokop Vodicka, Katerina Benesova, Andrea Janikova, David Belada, Andrea Hruskova, Heidi Mocikova, Juraj Duras, Katerina Steinerova, Alice Sykorova, Michal Masar, Jitka Dlouha, Petra Blahovcova, Marek Trneny
Journal: Blood
Blood (2024) 144 (Supplement 1): 1697.
https://doi.org/10.1182/blood-2024-208416
Published: 2024
Journal Articles

PCNSL Patients Treated with the Matrix Regimen in the Real World Have Similar Outcome to Those in the IELSG 32 Trial

Prokop Vodicka, Katerina Benesova, Andrea Janikova, David Belada, Veronika Hanackova, Heidi Mocikova, Juraj Duras, Katerina Steinerova, Eva Konirova, Tomas Prochazka, Kamila Polgarova, Jitka Dlouha, Petra Blahovcova, Marek Trneny
Journal: Blood
Blood (2024) 144 (Supplement 1): 1711.
https://doi.org/10.1182/blood-2024-204795
Published: 2024
Journal Articles

DLBCL Patients' Journey: From Symptoms to Diagnosis

Prokop Vodicka, Michal Masar, Magdalena Klanova, Katerina Benesova, Jan Koren, Pavel Klener, Petra Blahovcova, Sarka Hrabetova, Jitka Dlouha, Marek Trněný
Journal: Blood
Blood (2023) 142 (Supplement 1): 3140.
https://doi.org/10.1182/blood-2023-186207
Published: 2023
Journal Articles

Diagnosis to Treatment Interval Is the Most Significant Prognostic Factor Compared to Symptoms to Treatment As Well As to Contact to Treatment Intervals in DLBCL Patients

Prokop Vodicka, Michal Masar, Magdalena Klanova, Katerina Benesova, Jan Koren, Pavel Klener, Petra Blahovcova, Jitka Dlouha, Sarka Hrabetova, Marek Trněný
Journal: Blood
Blood (2023) 142 (Supplement 1): 4510.
https://doi.org/10.1182/blood-2023-186467
Published: 2023
Journal Articles

Risk of Central Nervous System Vs. Systemic Relapse in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: What Should We Focus on?

Magdalena Klanova, Samuel Hricko, Michal Masar, David Salek, Prokop Vodicka, Natasa Kopalova, Petra Blahovcova, Katerina Benesova, Jozef Michalka, Jan Koren, Andrea Janikova, Marek Trneny
Journal: Blood
Blood (2023) 142 (Supplement 1): 4479.
https://doi.org/10.1182/blood-2023-178208
Published: 2023
Journal Articles

Do the Control Cohorts of Phase III Randomized Trials Reflect the Real-World Results of DLBCL Patients?

Prokop Vodicka, Andrea Janikova, David Belada, Heidi Mocikova, Vit Prochazka, Juraj Duras, Katerina Steinerova, Vit Campr, Katerina Benesova, Samuel Hricko, Alice Sykorova, Petra Blahovcova, Radek Jaksa, Magdalena Klanova, Marek Trněný
Journal: Blood
Blood (2023) 142 (Supplement 1): 4485.
https://doi.org/10.1182/blood-2023-185620
Published: 2023
Journal Articles

The Outcome of Diffuse Large B-Cell Lymphoma Patients with Testicular Involvement - Real World Data

Heidi Mocikova, Andrea Janikova, Alice Sykorova, Vit Prochazka, Jan Pirnos, Juraj Duras, Katerina Kopeckova, Katerina Steinerova, Robert Pytlik, Petra Blahovcova, David Salek, Tomas Kozak, Veronika Bachanova, David Belada
Journal: Blood
Blood (2023) 142 (Supplement 1): 4482.
https://doi.org/10.1182/blood-2023-180155
Published: 2023
Journal Articles

Survival of Patients with Primary Mediastinal B-Cell Lymphoma Treated By Immunochemotherapy with or without Radiotherapy

Kamila Polgarova, Andrea Janíková, David Belada, Vit Prochazka, Juraj Ďuraš, Heidi Móciková, Kateřina Steinerová, Vít Campr, Petra Blahovcová, David Zogala, Václav Ptáčník, Marek Trneny
Journal: Blood
Blood (2022) 140 (Supplement 1): 3831–3832.
https://doi.org/10.1182/blood-2022-163113
Published: 2022
Journal Articles

How Relevant Are the Control Cohorts of Clinical Trials in Patients with Newly Diagnosed DLBCL in a Daily Practice?

Prokop Vodicka, Katerina Benesova, Andrea Janikova, David Belada, Heidi Mocikova, Jan Pirnos, Vit Prochazka, Juraj Duras, Katerina Kopeckova, Katerina Steinerova, Petra Blahovcova, Vit Campr, Pavel Klener, Jr., Alice Sykorova, Marek Trneny
Journal: Blood
Blood (2022) 140 (Supplement 1): 3775–3776.
https://doi.org/10.1182/blood-2022-159408
Published: 2022
Journal Articles

The Fate of Patients with Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Pavel Otahal, MD PhD, Andrea Janikova, MD PhD Assoc Prof, David Belada, MD PhD, Vit Prochazka, MD, Heidi Mocikova, MD PhD, Jan Pirnos, Juraj Ďuraš, Kateřina Kopečková, Vit Campr, MD PhD, Robert Pytlik, Petra Blahovcova, Mgr, Marek Trneny, MD CSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 5413.
https://doi.org/10.1182/blood-2018-99-117110
Published: 2018
Journal Articles

Destiny of Elderly Patients with Lymphoma Indicated for Autologous Stem Cell Transplantation (ASCT)

Robert Pytlik, Kamila Polgarova, MD, Marie Trnkova, Mgr, Pavel Klener, Jr., MD PhD Assoc Prof, Petra Blahovcova, Mgr, Blanka Vackova, MD, Eva Konířová, MD, Benešová Kateřina, MD PhD, Marek Trněný, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3289.
https://doi.org/10.1182/blood.V130.Suppl_1.3289.3289
Published: 2017